Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary neopterin in malignant lymphoma.

L Piccinini1, S Zironi, M Federico

  • 1Faculty of Oncology, University of Modena, Italy.

The International Journal of Biological Markers
|October 1, 1991
PubMed
Summary

Urinary neopterin levels correlate with lymphoma stage and activity. Higher neopterin indicates active disease, suggesting its potential as a prognostic marker for non-Hodgkin's lymphoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nerve-sparing total prostatectomy with or without adjuvant chemotherapy is associated with a low rate of surgical complications, long-term continence and improved survival in 22 dogs with T1 to T3 prostatic tumours.

The Journal of small animal practice·2026
Same author

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

ESMO open·2025
Same author

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.

British journal of cancer·2024
Same author

Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

Stereotactic Body Radiotherapy for Spine Oligometastases: A Multicentre Retrospective Study From the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

Area of Science:

  • Biochemistry
  • Oncology
  • Clinical Chemistry

Background:

  • Malignant lymphomas, including Hodgkin's disease and non-Hodgkin's lymphoma, represent a significant group of cancers.
  • Biomarkers are crucial for assessing disease activity, staging, and prognosis in lymphoma patients.
  • Neopterin, a marker of cellular immune activation, has been investigated for its role in various inflammatory and malignant conditions.

Purpose of the Study:

  • To investigate the relationship between urinary neopterin levels and the clinical characteristics of malignant lymphomas.
  • To determine if neopterin excretion can serve as a prognostic indicator in patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Main Methods:

  • Urinary neopterin levels were measured in 96 patients with malignant lymphomas (28 Hodgkin's disease, 68 non-Hodgkin's lymphoma).
  • Neopterin excretion was analyzed in relation to clinical stage, disease activity (active vs. remission), and histological subtypes.
  • Correlations between neopterin levels, erythrocyte sedimentation rate (ESR), and hemoglobin were assessed.
  • Longitudinal data were analyzed to explore the trend between neopterin levels and response to therapy.

Main Results:

  • Urinary neopterin excretion was significantly higher in patients with active disease compared to those in complete remission (p = 0.000).
  • Neopterin levels increased with advanced clinical stage (Stage III-IV vs. Stage I-II).
  • These associations were consistent across both Hodgkin's disease and non-Hodgkin's lymphoma subtypes.
  • Significant correlations were observed between neopterin excretion and ESR (r = 0.31, p = 0.003) and hemoglobin (r = -0.40, p = 0.000).

Conclusions:

  • Urinary neopterin levels are significantly associated with disease activity and clinical stage in malignant lymphomas.
  • Neopterin demonstrates potential as a valuable prognostic marker, particularly in non-Hodgkin's lymphoma.
  • Further longitudinal studies could solidify the role of neopterin in monitoring therapeutic response.

Related Experiment Videos